Numerous studies have demonstrated that SOX2 overexpression contributes to cancer pathogenesis and progression, including cancer cell proliferation, metastasis, tumor initiation, and cancer stem cell function in various tumors, such as lung and esophageal squamous cell carcinomas. This evidence concerns the gene SOX2 and neoplasm.